Visual acuity gradually improved for up to 5 years in patients with amblyopia, including adults, who were treated with ...

The FDA has approved the Janus kinase inhibitor upadacitinib for the treatment of giant cell arteritis in adults, the first ...

The proper “dosage” of exercise can be one of the most important components in weight management, according to a presenter at ...

With a workforce shortage and increasing patient demands, it is important for clinical practice leaders in primary care to ...

Healio spoke with Raj Chovatiya, MD, PhD, about results from the phase 3 ICONIC-LEAD trial presented at the 2025 Academy of ...

Living-related conjunctival limbal allograft should be first-line therapy for limbal stem cell deficiency, Edward J. Holland, ...

The likelihood for antibody-mediated rejection in lung transplant recipients was heightened with vs. without GLP-1 receptor ...

Physicians today find themselves in a rapidly changing health care environment.In this new era of practice aggregation and ...

Patients with kidney disease may have their own reasons for not putting their faith in the health care system, but physicians ...

A system hybridizing cardiac contractility modulation and implantable cardioverter defibrillation successfully converted ...

The FDA has approved Zevaskyn for the treatment of recessive dystrophic epidermolysis bullosa, the company announced in a ...

Screening rates for colorectal cancers were doubled, CRC-related mortality cut in half and racial disparities nearly ...